NCT06710405View on ClinicalTrials.gov

The Effect of Intraoperative Intravenous Lidocaine Infusion on Postoperative Pain and Recovery in Children (< 7 Years Old) Undergoing Thoracoscopic Surgery

PHASE4RecruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

December 9, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Pain Management After Surgery
Interventions
DRUG

Lidocaine (drug)

a single bolus dose of lidocaine 1.5 mg/kg is administered concurrently with the induction of anesthesia, followed by a continuous infusion of lidocaine at a rate of 1.5 mg/kg/hr.

DRUG

Saline infusion (placebo)

Continuous infusion of normal saline in the same volume as that administered to the lidocaine group.

Trial Locations (1)

03080

RECRUITING

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Seoul National University Hospital

OTHER

NCT06710405 - The Effect of Intraoperative Intravenous Lidocaine Infusion on Postoperative Pain and Recovery in Children (< 7 Years Old) Undergoing Thoracoscopic Surgery | Biotech Hunter | Biotech Hunter